Merck Sharp & Dohme-Chibret Draws Form 483 for Sterilization Failures

By Sam | February 12, 2017

FDA investigators handed France-based drug manufacturer Merck Sharp & Dohme-Chibret Laboratories a Form 483 after an inspection revealed sterilization issues and drug batch failures were not reported on time.
Source: Drug GMP Report

Posted in Drug GMP Report